Moreover, a recent study reported that PD-L1 was induced by expression of mutant EGFR in bronchial epithelial cells, and EGFR inhibitors could reduce PD-L1 expression in NSCLC cell lines of activated EGFR25. The gene discussed is CD274; the disease is non-small cell lung carcinoma.